What are the characteristics of a lisinopril-induced cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Characteristics of Lisinopril-Induced Cough

Lisinopril-induced cough is characteristically a dry, persistent, nonproductive cough with a tickling or scratching sensation in the throat that worsens at night and can occur anywhere from hours after the first dose to months after starting therapy 1.

Clinical Presentation

The cough has several distinctive features that help identify it:

  • Quality: Dry, nonproductive, and persistent with a tickling or scratching throat sensation 1
  • Timing of onset: Can begin within hours of the first dose or be delayed for weeks to months after initiation 1
  • Nocturnal worsening: Approximately 79% of patients report increased intensity at night 2, with sleep interference being common 3
  • Not dose-dependent: The cough occurs regardless of lisinopril dosage 1, 2, 4

Epidemiology and Risk Factors

The incidence varies widely in reported studies:

  • Overall incidence: Ranges from 5-35% in treated patients 1, though the FDA label reports cough occurring 2.5% more frequently than placebo 5
  • Female predominance: Women develop ACE inhibitor-induced cough 2-3 times more frequently than men 1, 6, 2, 4. In one study, 12.6% of women vs 4.4% of men reported cough spontaneously 6
  • Nonsmokers: More likely to develop cough than smokers 1, 6
  • Ethnicity: Higher incidence in persons of Chinese origin 1

Diagnostic Confirmation

To confirm lisinopril as the cause, discontinue the medication regardless of the temporal relationship between starting the drug and cough onset 1. The diagnosis is confirmed by:

  • Resolution timeframe: Cough typically resolves within 1-4 weeks after discontinuation 1
  • Important caveat: In a subgroup of patients, resolution may be delayed up to 3 months 1
  • Cough reduction pattern: 50% reduction within 3 days, complete resolution within 10 days in most cases 4

Mechanism

The cough likely results from accumulation of bradykinin and substance P (normally degraded by ACE) in the upper respiratory tract, which stimulates lung afferent C fibers and may trigger prostaglandin E2 production 1, 7.

Potential Complications

The cough can be severe enough to cause:

  • Urinary stress incontinence (reported in 5 women in one series) 3
  • Rectal and vaginal prolapse 3
  • Significant functional impairment with some patients feeling incapacitated 3
  • Sleep disruption 3

Clinical Pitfall

Do not assume the temporal relationship matters—ACE inhibitors should be considered causative in any patient with chronic cough taking these medications, even if the cough started long after drug initiation 1. Additionally, ACE inhibitor therapy may sensitize the cough reflex and potentiate other causes of chronic cough 1, so stopping the medication may still be beneficial even when other pulmonary pathology is present.

References

Research

Angiotensin converting enzyme inhibitors and cough--a north Indian study.

The Journal of the Association of Physicians of India, 1998

Research

Characterization of cough associated with angiotensin-converting enzyme inhibitors.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1991

Research

ACE inhibitors and cough.

Angiology, 1994

Research

Female preponderance for lisinopril-induced cough in hypertension.

American journal of hypertension, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.